|
gptkbp:instanceOf
|
gptkb:drug
alcohol dehydrogenase inhibitor
|
|
gptkbp:approvalYear
|
1997
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
V03AB34
|
|
gptkbp:boilingPoint
|
181-182°C
|
|
gptkbp:CASNumber
|
7554-65-6
|
|
gptkbp:chemicalFormula
|
C4H8N2
|
|
gptkbp:contraindication
|
hypersensitivity to fomepizole
|
|
gptkbp:eliminationHalfLife
|
7-11 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:firstSynthesized
|
1950s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
fomepizole
|
|
gptkbp:KEGGID
|
D04124
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits alcohol dehydrogenase
|
|
gptkbp:meltingPoint
|
25-27°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
84.12 g/mol
|
|
gptkbp:origin
|
synthetic
|
|
gptkbp:otherName
|
gptkb:4-methylpyrazole
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
3297
3415
CHEMBL1201
DB01219
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
metallic taste
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:UNII
|
7LJ087RS6F
|
|
gptkbp:usedFor
|
ethylene glycol poisoning
methanol poisoning
|
|
gptkbp:bfsParent
|
gptkb:methanol
|
|
gptkbp:bfsLayer
|
6
|